Skip to content

AtriClip™ LAA Exclusion System ACH135Recalls & reported problems

Atricure, Inc. · AtriClip® Gilinov-Cosgrove LAA Exclusion System 35 · Class 2 · Implant

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 10840143900051), received between Dec 7, 2022 and Dec 7, 2022 — classified as 1 malfunction.

The most frequently reported specific device problem is “Tear, Rip or Hole in Device Packaging” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Tear, Rip or Hole in Device Packaging1

Patient problems

  • No Clinical Signs, Symptoms or Conditions1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionDec 7, 2022Tear, Rip or Hole in Device Packaging; Tear, Rip or Hole in Device Packaging

    ON (B)(6) 2022 WHEN REMOVING AN ACH135 CLIP, A HOLE WAS NOTICED IN THE TYVEK. ANOTHER CLIP WAS OPENED TO COMPLETE THE CASE. THERE WAS NO PATIENT IMPACT.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 15931576 ↗

Other Clip, Implantable devices

All Clip, Implantable devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page